VCYT Veracyte, Inc.
$40.87▼ -2.76%
Healthcare
Other
After hours
$40.87▲ +0.00%
Sep 11, 7:30 PM ET
Volume 1.00M
Avg Volume (10D) 1.17M
Key Metrics & Fundamentals
Market Cap
$3.29B
P/E Ratio
29.2
Div Yield
–%
52W Range
29.46 - 60.91
% vs 50 MA
-17.11%
% vs 200 MA
-4.23%
RSI-14
37.9
MACD Histogram
+0.1900
Beta (1Y vs SPY)
1.44
Free Cash Flow
$42.97M
Gross Rev
$150.32M
Gross Profit
$108.55M
EBITDA
$31.70M
COGS
$41.77M
Operating Exp
$85.57M
Operating Income
$22.98M
EBIT
$22.98M
Pretax Income
$26.52M
Net Income
$25.49M
EPS (Diluted)
0.31
Price & Volume History
Loading chart…
Recent News
Zacks Industry Outlook Highlights Veracyte, Globus Medical and UFP Technologies
Zacks · Sep 10, 2026 7:36 AM
UBS Adjusts Price Target on Veracyte to $65 From $52, Keeps Buy Rating
MT Newswires · Sep 9, 2026 1:37 PM
Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire · Sep 1, 2026 8:05 PM
Is it Worth Adding Veracyte Stock to Your Portfolio Now?
Zacks · Aug 26, 2026 2:17 PM
VCYT Drops 25.3% in the Past Month. Is the Sell-Off an Opportunity?
Zacks · Aug 25, 2026 2:25 PM
Down 30.2% in 4 Weeks, Here's Why Veracyte (VCYT) Looks Ripe for a Turnaround
Zacks · Aug 17, 2026 1:35 PM
Veracyte Q2 Earnings Call Highlights
MarketBeat · Aug 1, 2026 2:03 AM
Needham Raises Price Target on Veracyte to $69 From $57, Keeps Buy Rating
MT Newswires · Jul 31, 2026 11:18 AM
Is Veracyte (VCYT) Fully Valued After Raising 2026 Revenue Guidance?
Simply Wall St. · Jul 31, 2026 10:06 AM
Veracyte Inc (VCYT) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Launches ...
GuruFocus.com · Jul 31, 2026 5:03 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See VCYT's money flow as a full page
Social Sentiment
No Reddit posts found for VCYT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.